Center for Outpatient Health/Washington University in St. Louis
St Louis, Missouri, 63110, United States
NCT Number: NCT03885791
This is a placebo-controlled, randomized controlled trial to investigate the role of vaginal cryotherapy on pelvic floor myofascial pain in women. This study involves randomizing patients who are found to have pelvic floor myofascial pain on examination into one of two treatment groups: transvaginal cryotherapy or transvaginal application of a room-temperature tube. Patients will be followed up at two different time points in order to assess response to treatment. Follow-up times include immediately after application (Specific Aim #1) and two weeks following use of the intervention alone (Specific Aim #2). Patients will receive verbal and written instructions on using the intravaginal tubes by the research assistant who will not be blinded to treatment allocation. Patients will not be blinded to their treatment assignment but will not be given information on the alternative treatment. Patients will be referred to pelvic floor PT, which is considered the standard of care for treatment of pelvic floor myofascial pain at this time. As it typically takes 2-3 weeks to get in to see one of the pelvic floor PT providers at Wash U, follow up for this study will be completed prior to their attendance at pelvic floor PT. Patients will complete validated questionnaires assessing their pain, other pelvic floor symptoms, and acceptance of the intervention as a treatment option at the follow up time points.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Both groups will be given the same instructions for use, which will include intravaginal placement of one tube for 10 minutes while resting in a supine position. A lubricant may be used for comfort with insertion.
Patients will perform their first intervention in the office with a repeat examination within 10 minutes of completing therapy. Patients participating in Specific Aims #2 will perform the intervention once daily at home. Patients will be asked to complete a short diary for each session, which will include the time of day, duration of application, pain score prior to and after application, and presence of any pelvic floor disorder symptoms prior to and after application.
Time frame: 10-15 minutes (Pre- to post-treatment)
Primary outcome is change in pelvic floor myofascial pain scores at each site (bilateral OI and LA) as measured on a 0-10 visual pain rating scale where 0 indicates no pain on palpation and 10 indicates 'worst pain imaginable' on palpation.
Time frame: 2 weeks
Short form of the validated questionnaire to assess presence and degree of bother of common pelvic floor symptoms
Time frame: 2 weeks
Short form of the validated questionnaire to assess impact of pelvic floor symptoms on daily activities
Time frame: 2 weeks
Short form of the validated questionnaire to assess the impact of pelvic floor symptoms on sexual activity
Time frame: 2 weeks
Validated questionnaire to assess presence and degree of bother of lower urinary tract symptoms
Time frame: 2 weeks
Validated questionnaire to assess lower urinary tract symptoms
Washington University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07329218
Pelvic Floor Myofascial Pain
Damietta, Egypt
View Trial DetailsNCT07241637
Endometriosis, Fatigue
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07705516
Neurologic Manifestations, Pain
Poltava, Poltava Oblast, Ukraine
View Trial DetailsNCT05570786
Endometriosis, Female Urogenital Diseases
São Paulo, Brazil
View Trial Details